COMPOUND PROFILE / PEPTIDES & ANALOGUES
DSIP.
Research draftDSIP is delta-sleep-inducing peptide, also called emideltide.
Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.
Targeted source and identity review, not a systematic review or complete regulatory audit.
Overview
DSIP is delta-sleep-inducing peptide, also called emideltide.
Mechanism
Sleep-related and neuroendocrine effects have been proposed; a validated therapeutic mechanism remains uncertain.
Human research
Small older human studies exist, with limited evidence sufficient to establish reliable insomnia treatment.
Preclinical & other research
Animal and experimental sleep work generated the original rationale.
Safety & unknowns
Study size, age and formulation restrict safety conclusions, especially for current injectable products.
Regulatory status
No therapeutic approval is established in the reviewed sources.
Reported use & evidence
The supplied DSIP profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.
Sources & references
Follow the cited records and registered research. Profiles remain research drafts.